Pulmonary Hypertension Trial, Recruiting (NCT07430943)

Pulmonary Hypertension Trial, Recruiting NCT07430943 Sponsor: Mona Lichtblau Condition: Pulmonary Hypertension

Printed from Voxsanity (voxsanity.com.au) — NCT07430943 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pulmonary Hypertension

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People of any sex or gender
People who are older than 18 years of age
People who have been prescribed a pulmonary rehabilitation (APR) program by a doctor and are currently taking part in that program at the University Hospital Zurich (USZ)
People who are physically and mentally able to follow instructions and to stand or walk for up to one hour (short sitting breaks are allowed if needed)

Who may not be able to join:

People who need extra oxygen that cannot be carried in a portable backpack system — for example, those who rely on large oxygen cylinders on wheels, which can increase the risk of falling
People who are unable to follow the study procedures because of language differences, psychological conditions, or physical limitations affecting the joints or bones that prevent standing or walking for up to one hour
People who need walking aids to keep their balance, such as walking sticks, a rollator, or similar devices

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mona Lichtblau, University of Zurich

Phone: +41 442552220

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07430943

Sponsor: Mona Lichtblau

Phase: Not Applicable

Status: Recruiting

Condition: Pulmonary Hypertension

Trial contact: +41 442552220

More information: https://clinicaltrials.gov/study/NCT07430943

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People of any sex or gender
People who are older than 18 years of age
People who have been prescribed a pulmonary rehabilitation (APR) program by a doctor and are currently taking part in that program at the University Hospital Zurich (USZ)
People who are physically and mentally able to follow instructions and to stand or walk for up to one hour (short sitting breaks are allowed if needed)

Who may not be able to join:

People who need extra oxygen that cannot be carried in a portable backpack system — for example, those who rely on large oxygen cylinders on wheels, which can increase the risk of falling
People who are unable to follow the study procedures because of language differences, psychological conditions, or physical limitations affecting the joints or bones that prevent standing or walking for up to one hour
People who need walking aids to keep their balance, such as walking sticks, a rollator, or similar devices

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mona Lichtblau

Registry

ClinicalTrials.gov

Start date

5 March 2026

Est. completion

28 February 2027

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Acceptability, appropriateness and feasibility of Street Racket

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov